Schedule 13G ownership disclosure

Whitehawk Therapeutics, Inc.

Common Stock · CUSIP: 00032Q104

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • EcoR1 Capital, LLC

    Shares: 345,253.00 · Class: 1.4%

  • Oleg Nodelman

    Shares: 345,253.00 · Class: 1.4%

  • EcoR1 Capital Fund Qualified, L.P.

    Shares: 324,365.00 · Class: 1.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-25-000158
Form type
SCHEDULE 13G/A
Filer
Whitehawk Therapeutics, Inc.
CIK
CIK 1422142
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub